glucagon-like-peptide-1 and Carcinoma--Basal-Cell

glucagon-like-peptide-1 has been researched along with Carcinoma--Basal-Cell* in 1 studies

Other Studies

1 other study(ies) available for glucagon-like-peptide-1 and Carcinoma--Basal-Cell

ArticleYear
GLP-1 Analogs and SGLT2 Inhibitors Do Not Increase Risk of Bullous Pemphigoid.
    The Journal of investigative dermatology, 2021, Volume: 141, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Case-Control Studies; Dipeptidyl-Peptidase IV Inhibitors; Female; Finland; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Male; Middle Aged; Pemphigoid, Bullous; Retrospective Studies; Risk; Sodium-Glucose Transporter 2 Inhibitors

2021